NCT01414192

A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204)

Model-Observation Bridging Study (MOBS) for Ezetrol® and Inegy®

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 3,215 (actual)
• Sponsor: Organon and Co · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is being done to provide valid data on the evolution of a cohort of French participants treated with ezetimibe, alone or in combination with a statin, to be used in simulation models for cardiovascular disease (CVD). Patterns of drug use, evolution of risk factors for CVD, cardiovascular morbidity and mortality, and goal attainment in low density lipoprotein cholesterol (LDL-C) levels over time will be analyzed.

Conditions

• Dyslipidemia
• Hypercholesterolemia

Timeline

• Start date: 2008-11-15
• Primary completion: 2014-09-15
• Completion: 2014-09-15
• First posted: 2011-08-11
• Last updated: 2024-09-05
• Results posted: 2016-01-08